Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are among the most common therapeutic agents used in medical practice, yet their mechanisms of action are only partly understood. This review summarizes our understanding of how glucocorticoids inhibit inflammation and give rise to side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids, which are among the most potent anti-inflammatory hormones in the body46,47.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [47]
In the citing paper
“HPA axis activation and subsequent secretion of glucocorticoids in response to stressor exposure typically acts to prevent pro-inflammatory activity via inhibition of NFκB (Rhen and Cidlowski, 2005).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Rhen and Cidlowski, 2005
In the citing paper
“cortisol is one of the most potent anti-inflammatory hormones in the body.9”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“major depression is a disorder that is characterized by hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and increased release of glucocorticoids”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“Corticosteroids (e.g., methylprednisolone, prednisolone, prednisone) are commonly used immunosuppressants for their global inhibitory effects on innate and adaptive immunity (36).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [36]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Retracted: Effects of Vitamin K2 on Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383782 · Cited by 66
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,128
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Research works printed but not linked: 4
- Rhen T, Cidlowski JA. Steroid hormone action. In: Strauss JF III, Barbieri RL, eds. Yen and Jaffe's reproductive endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2004:155-74.
- 10.1210/mend.15.7.0667 · doi:10.1210/mend.15.7.0667 · Paper page
- Roviezzo F, 2002, J Physiol Pharmacol, 53, 541
- Mitch WE, 2000, Trans Am Clin Climatol Assoc, 111, 258
Cited by
Items 901–1,000 of 1,016
Effect of Formulation and Processing Variables on Dexamethasone Entrapment and Release of Niosomes
Mavaddati, M. A., Moztarzadeh, F., & Baghbani, F. (2015) · Journal of Cluster Science · doi:10.1007/s10876-015-0908-4 · Cited by 37
Improved Synthesis of Fluticasone Propionate
Zhou, J., Jin, C., & Su, W. (2014) · Organic Process Research & Development · doi:10.1021/op5001226 · Cited by 37
Host-Derived Leukotriene B4 Is Critical for Resistance against Invasive Pulmonary Aspergillosis
Caffrey-Carr, A. K., Hilmer, K. M., Kowalski, C. H., Shepardson, K. M., Temple, R. M., Cramer, R. A., & Obar, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01984 · Cited by 39
“Treatment with glucocorticoids leads to inhibition of cytosolic phospholipase A2α through the induction of lipocortin-1, blocking the conversion of phospholipids to arachidonic acid (40).”
BackgroundArmer, J. S., Clevenger, L., Davis, L. Z., Cuneo, M. G., Thaker, P. H., Goodheart, M. J., Bender, D., Dahmoush, L., Sood, A. K., Cole, S. W., et al. (2018) · Cancer · doi:10.1002/cncr.31570 · Cited by 39
Gareb, B., Dijkstra, G. D. H., Kosterink, J. G. W., & Frijlink, H. W. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.019 · Cited by 37
Napp, J., Markus, M. A., Heck, J. G., Dullin, C., Möbius, W., Gorpas, D. S., Feldmann, C., & Alves, F. (2018) · Theranostics · doi:10.7150/thno.28324 · Cited by 39
“In particular, the long term use of systemic and/or high doses of GCs is associated with multiple severe adverse effects such as immunosuppression, hypertension, hyperglycemia, hydroelectrolytic disorders, adrenal insufficiency, weight gain, increased skin fragility, myopathy, osteoporosis, metabolic disturbances and…”
BackgroundA miR‐29a‐driven negative feedback loop regulates peripheral glucocorticoid receptor signaling
Glantschnig, C., Koenen, M., Gil‐Lozano, M., Karbiener, M., Pickrahn, I., Williams‐Dautovich, J., Patel, R., Cummins, C. L., Giroud, M., Hartleben, G., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801385rr · Cited by 40
“One proposed source of GC resistance is ligand-induced down-regulation of GR expression levels (8, 9).”
BackgroundFeng, Y. M., Hu, Y., Hou, Z., Sun, Q., Jia, Y., & Zhao, R. (2019) · Cell Stress and Chaperones · doi:10.1007/s12192-019-01034-7 · Cited by 38
Yeon, M., Choi, H., & Jun, H. (2020) · Nutrients · doi:10.3390/nu12051255 · Cited by 38
“DEX belongs to the family of GCs and is used as an immunosuppressive drug [36].”
BackgroundHarypursat, V., Zhou, Y., Tang, S., & Chen, Y. (2020) · AIDS Research and Therapy · doi:10.1186/s12981-020-00293-0 · Cited by 41
Prevalence of Persistent Corneal Epithelial Defects in Chronic Ocular Graft-Versus-Host Disease
Sinha, S., Singh, R. B., Dohlman, T. H., Wang, M., Taketani, Y., Yin, J., & Dana, R. (2020) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2020.05.035 · Cited by 37
Postoperative Dexamethasone Following Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis
Fletcher, N. D., Ruska, T., Austin, T. M., Guissé, N. F., Murphy, J. S., & Bruce, R. W. (2020) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.20.00259 · Cited by 40
Ghasemzadeh, M., Ahmadi, J., & Hosseini, E. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.03.022 · Cited by 41
“Steroids are commonly used anti-inflammatory drugs that quench inflammatory state interfering with NF-κB, the key inflammatory transcriptional regulator, while also suppressing immune responses [236].”
Polymeric delivery systems for dexamethasone
Urbańska, J., Karewicz, A., & Nowakowska, M. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.12.020 · Cited by 42
Eicosanoid Release Is Increased by Membrane Destabilization and CFTR Inhibition in Calu-3 Cells
Borot, F., Vieu, D., Faure, G., Fritsch, J., Colas, J., Moriceau, S., Baudouin-Legros, M., Brouillard, F., Ayala‐Sanmartín, J., Touqui, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007116 · Cited by 39
“Since cPLA2a releases the acyl chain at the sn-2 position of phospholipids leading to a subsequent synthesis of eicosanoids, the observed decrease in the expression of ANXA1 has been suggested to be at the start point of this cascade [16,19].”
The postoperative management of pain from intracranial surgery in pediatric neurosurgical patients
Shay, J. E., Kattail, D., Morad, A. H., & Yaster, M. (2014) · Pediatric Anesthesia · doi:10.1111/pan.12444 · Cited by 37
Yoshikawa, N., Nagasaki, M., Sano, M., Tokudome, S., Ueno, K., Shimizu, N., Imoto, S., Miyano, S., Suematsu, M., Fukuda, K., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90767.2008 · Cited by 39
Interaction and Functional Interference of Glucocorticoid Receptor and SOCS1
Haffner, M. C., Jurgeit, A., Berlato, C., Geley, S., Parajuli, N., Yoshimura, A., & Doppler, W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801041200 · Cited by 35
Cittadino, E., Ferraretto, M., Torres, E., Maiocchi, A., Crielaard, B. J., Lammers, T., Storm, G., Aime, S., & Terreno, E. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.08.022 · Cited by 36
Keenan, C. R., Radojicic, D., Li, M., Radwan, A. M., & Stewart, A. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.006 · Cited by 39
A Nonsteroidal Glucocorticoid Receptor Agonist Inhibits Allergen-induced Late Asthmatic Responses
Gauvreau, G. M., Boulet, L., Leigh, R., Cockcroft, D. W., Killian, K. J., Davis, B. E., Deschesnes, F., Watson, R. M., Swystun, V. A., Mårdh, C. K., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201404-0623oc · Cited by 36
What Are Endocrine Disrupters and Where Are They Found?
Darbre, P. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801139-3.00001-6 · Cited by 36
Cortisone and dexamethasone inhibit myogenesis by modulating the AKT/mTOR signaling pathway in C2C12
Kim, J., Park, M. Y., Kim, H., Park, Y., & Whang, K. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1210502 · Cited by 38
Manry, J., Nédélec, Y., Fava, V. M., Cobat, A., Orlova, M., Thuc, N. V., Thai, V. H., Laval, G., Barreiro, L. B., & Schurr, E. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006952 · Cited by 42
Intracellular coassembly boosts the anti-inflammation capacity of dexamethasone
Tang, W., Yang, J., Zhao, Z., Lian, Z., & Liang, G. (2017) · Nanoscale · doi:10.1039/c7nr07197c · Cited by 37
Oakley, R. H., Ramamoorthy, S., Foley, J. F., Busada, J. T., Lu, N. Z., & Cidlowski, J. A. (2018) · The FASEB Journal · doi:10.1096/fj.201701153r · Cited by 37
“Glucocorticoids are steroid hormones necessary for life that regulate many different physiologic processes, including growth, reproduction, intermediary metabolism, immune and inflammatory responses, cognition, behavior, and cardiovascular function (1).”
BackgroundSelf-citationInterruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy
Strianese, D., & Rossi, F. (2019) · Eye · doi:10.1038/s41433-018-0315-9 · Cited by 39
Kumar, P., & Thompson, E. A. (2019) · Biomolecules · doi:10.3390/biom9030095 · Cited by 37
Cruz‐Topete, D., Oakley, R. H., Carroll, N., He, B., Myers, P., Xu, X., Watts, M. N., Trosclair, K., Glasscock, E., Dominic, P. S., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011012 · Cited by 38
“Glucocorticoids are primary stress-induced hormones that function as potent anti-inflammatory and immune regulators.(5,7) In addition to the actions of these hormones on the immune system, glucocorticoids also have significant effects on the regulation of embryonic development, intermediate metabolism, central nervous…”
BackgroundSelf-citationOstler, J. B., Thunuguntla, P., Hendrickson, B. Y., & Jones, C. (2020) · Journal of Virology · doi:10.1128/jvi.01776-20 · Cited by 37
“In addition to directly influencing viral gene expression and replication, the anti-inflammatory and immunosuppressive properties of corticosteroids (26, 72) are likely to promote virus spread following stressful stimuli.”
BackgroundAcetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity
Pérez, M. M., Pimentel, V. E., Fuzo, C. A., Silva-Neto, P. V. D., Toro, D. M., Fraga‐Silva, T. F. D. C., Gardinassi, L. G., Oliveira, C. N. S., Souza, C. O. S., Neto, N. T., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200079 · Cited by 38
Rollema, C., van Roon, E. N., van Boven, J. F. M., Hagedoorn, P., Klemmeier, T., Kocks, J., Metting, E., Elberink, H. N. G. O., Peters, T. T. A., Giorgi, M. R. M. S., et al. (2022) · Clinical & Experimental Allergy · doi:10.1111/cea.14212 · Cited by 40
Glucocorticoid treatment in patients with complex regional pain syndrome: A systematic review
van den Berg, C., de Bree, P., Huygen, F. J. P. M., & Tiemensma, J. (2022) · European Journal of Pain · doi:10.1002/ejp.2025 · Cited by 41
“Glucocorticoids (i.e. the most effective anti- inflammatory drug) may play a key role in CRPS treatment (Barnes, 2010; Rhen & Cidlowski, 2005).”
BackgroundTopical Anti-Inflammatory Agents for Non-Infectious Uveitis: Current Treatment and Perspectives
Balasubramaniam, B., Chong, Y. J., Azzopardi, M., Logeswaran, A., & Denniston, A. K. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s288294 · Cited by 39
“Abbreviations: NF-κB, Nuclear factor-κB; IκB, inhibitory protein of NF-κB; COX-2, cyclooxygenase-2; c-Jun/Fos, inflammation transcription factor polypeptide subunits; MAPK, mitogen-activated protein kinases; cPLA2α, cytosolic phospholipase A2α; 5-LOX, 5-lipoxygenase.(27)”
BackgroundInfluentialPathogenetic mechanisms and treatment targets in cerebral malaria
Hadjilaou, A., Brandi, J., Riehn, M., Friese, M. A., & Jacobs, T. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00881-4 · Cited by 41
Man, X., Li, W., Chen, J., Zhou, J., Landeck, L., Zhang, K.-H., Mu, Z., Li, C., Cai, S., & Zheng, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1255-3 · Cited by 37
Identification of a Novel Mucin Gene HCG22 Associated With Steroid-Induced Ocular Hypertension
Jeong, S., Patel, N. N., Edlund, C. K., Hartiala, J., Hazelett, D. J., Itakura, T., Wu, P., Avery, R. L., Davis, J. L., Flynn, H. W., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14803 · Cited by 39
“As part of the natural feedback mechanism that turns down the inflammatory response, they are useful for treating a wide variety of diseases.(26) Complicating this, however, is the considerable interindividual variability and tissue-specific GC sensitivity among individuals, which can cause a variety of systemic side…”
BackgroundKook, I., Doster, A. R., & Jones, C. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0339-x · Cited by 37
“Finally, a bICP0 expression plasmid stimulates plaque-forming efficiency of BHV-1 DNA transfected into cultured cells (Geiser et al. Fig.”
BackgroundManagement of early nasal polyposis using a steroid‐impregnated nasal dressing
More, Y. I., Willen, S., & Catalano, P. J. (2011) · International Forum of Allergy & Rhinology · doi:10.1002/alr.20067 · Cited by 36
Rani, C. S. S., Elango, N., Wang, S.-S., Kobayashi, K., & Strong, R. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051219 · Cited by 38
“Glucocorticoids use several mechanisms to bring about transactivation or transrepression of genes (De Bosscher et al., 2003; Rhen and Cidlowski, 2005; Newton and Holden, 2007).”
Workman, A. M., Zhu, L., Keel, B. N., Smith, T. P. L., & Jones, C. (2018) · Journal of Virology · doi:10.1128/jvi.01937-17 · Cited by 38
Dmytriv, T. R., Tsiumpala, S. A., Semchyshyn, H. M., Storey, K. B., & Lushchak, V. I. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1222826 · Cited by 36
Disrupted glucocorticoid—Immune interactions during stress response in schizophrenia
Chiappelli, J., Shi, Q., Kodi, P., Savransky, A., Kochunov, P., Rowland, L. M., Nugent, K. L., & Hong, L. E. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.09.010 · Cited by 38
“Cortisol exerts anti-inflammatory effects by inhibiting transcription of pro-inflammatory cytokines, among other mechanisms (Coutinho and Chapman 2011; Rhen & Cidlowski 2005).”
BackgroundResultTakei, K., Denda, S., Kumamoto, J., & Denda, M. (2013) · Experimental Dermatology · doi:10.1111/exd.12224 · Cited by 35
Pretorius, C. J., Galligan, J. P., McWhinney, B. C., Briscoe, S. E., & Ungerer, J. P. J. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.02.019 · Cited by 35
Wong, C.-Y., Bezhaeva, T., Rothuizen, T. C., Metselaar, J. M., de Vries, M. R., Verbeek, F. P. R., Vahrmeijer, A. L., Wezel, A., van Zonneveld, A. J., Rabelink, T. J., et al. (2016) · Scientific Reports · doi:10.1038/srep30439 · Cited by 41
Canine Idiopathic Chronic Hepatitis
Bexfield, N. (2017) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2016.11.012 · Cited by 43
Hormonal therapy in traumatic spinal cord injury.
Ludwig, P. E., Patil, A. A., Chamczuk, A. J., & Agrawal, D. K. (2017) · Europe PMC (PubMed Central) · Cited by 45
Production and Characterization of Anti-Inflammatory Monascus Pigment Derivatives
Choe, D., Song, S. M., Shin, C. S., Johnston, T. V., Ahn, H. J., Kim, D., & Ku, S. (2020) · Foods · doi:10.3390/foods9070858 · Cited by 38
“, glucocorticoids) are one of the effective approaches to treating chronic inflammation, but prolonged or high-dose glucocorticoid therapy has multiple side effects [12].”
BackgroundDrug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment
Kifle, Z. D., Ayele, A. G., & Enyew, E. F. (2021) · Journal of Environmental and Public Health · doi:10.1155/2021/6631721 · Cited by 37
“However, their anti-inflammatory effect can decrease systemic inflammation, reduce fluid accumulation in the lung tissue, and prevent more alveolar damage from spreading, thus improving hypoxia and decreasing the risk of respiratory failure [107].”
BackgroundS3 guideline Atopic dermatitis: Part 2 ‐ Systemic treatment
Werfel, T., Heratizadeh, A., Aberer, W., Augustin, M., Biedermann, T., Bauer, A., Fölster‐Holst, R., Kahle, J., Kinberger, M., Nemat, K., et al. (2023) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15229 · Cited by 52
“3 Despite the regular use of systemic glucocorticosteroids in clinical practice, there are very few studies on adult and pediatricpatientswithAD.”
BackgroundNF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG2 hepatoma cell line
Zuo, Q., Liu, S., Li, Z., Li, B., Zhou, Y., Guo, R. F., & Huang, L. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.187 · Cited by 37
Antipyretic and Antioxidant Activities of the Aqueous Extract ofCornu Bubali(Water Buffalo Horn)
Liu, R., Wang, M., & Duan, J. (2010) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x10007853 · Cited by 35
ZHANG, K., Bai, X., Li, R., Xiao, Z., Chen, J., Yang, F., & Li, Z. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1014 · Cited by 34
Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock
Hicks, C. W., Sweeney, D. A., Danner, R. L., Eichacker, P. Q., Suffredini, A. F., Feng, J. H., Sun, J., Behrend, E. N., Solomon, S. B., & Natanson, C. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822efa14 · Cited by 35
“In contrast to the strong antiinflammatory effects of glucocorticoids (15), mineralocorticoid receptor-specific ligands have relatively weaker antiinflammatory effects (16) and have not been associated with overt immune suppression.”
ResultThe Glucosafe system for tight glycemic control in critical care: A pilot evaluation study
Pielmeier, U., Andreassen, S., Juliussen, B., Chase, J. G., Nielsen, B. S., & Haure, P. (2009) · Journal of Critical Care · doi:10.1016/j.jcrc.2009.10.003 · Cited by 35
“Furthermore, the treatment with steroids of various types is common in our ICU and can increase insulin resistance [29].”
BackgroundGlucocorticosteroids as antioxidants in treatment of asthma and COPD
Sadowska, A. M., Klebe, B., Germonpré, P. R., & Backer, W. A. D. (2006) · Steroids · doi:10.1016/j.steroids.2006.10.007 · Cited by 35
Kinin B1 Receptor Antagonist BI113823 Reduces Acute Lung Injury*
Nasseri, S., Gurusamy, M., Jung, B., Lee, D., Khang, G., Doods, H. N., & Wu, D. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001268 · Cited by 35
Liu, C., Guo, C., Wang, W., Zhu, P., Li, W., Mi, Y., Myatt, L., & Sun, K. (2016) · Endocrinology · doi:10.1210/en.2016-1406 · Cited by 35
The Effect of Glucocorticoids on Canine Lymphocyte Marker Expression and Apoptosis
Ammersbach, M., Kruth, S. A., Sears, W., & Bienzle, D. (2006) · Journal of Veterinary Internal Medicine · doi:10.1892/0891-6640(2006)20[1166:teogoc]2.0.co;2 · Cited by 35
Fischer, H. J., Schweingruber, N., Lühder, F., & Reichardt, H. M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.001 · Cited by 34
“Since GCs are capable of activating PI3 K, this could explain how GCs increase CXCR4 expression (Rhen and Cidlowski, 2005).”
BackgroundGene therapy vector-related myocarditis
Silver, E., Argirò, A., Hong, K. N., & ADLER, E. D. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131617 · Cited by 36
Staudacher, K., Bâldea, I., Kisselbach, J., Staudacher, I., Rahm, A., Schweizer, P. A., Becker, R., Katus, H. A., & Thomas, D. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.210666 · Cited by 37
“…different N-terminal domains from a single mRNA by ATI has been shown to alter subcellular localization and function of transcription and growth factors, cell cycle regulators, hormone receptors and protein kinases (Prats et al. 1989; Lu & Cidlowski, 2005; Rhen & Cidlowski, 2005; Cai et al. 2006).”
BackgroundElectroacoustic Stimulation: Now and into the Future
Irving, S., Gillespie, L. N., Richardson, R. T., Rowe, D., Fallon, J. B., & Wise, A. K. (2014) · BioMed Research International · doi:10.1155/2014/350504 · Cited by 38
Regulation of Eosinophilia in Asthma—New Therapeutic Approaches for Asthma Treatment
Cusack, R. P., Whetstone, C. E., Xie, Y., Ranjbar, M., & Gauvreau, G. M. (2021) · Cells · doi:10.3390/cells10040817 · Cited by 37
“GCs inhibit lymphocyte activation and inflammatory mediator expression and induce lymphocyte apoptosis, actively reducing total blood lymphocyte numbers in asthmatics [16].”
BackgroundPimentel, T. A., Sampaio, A. L. F., D’Acquisto, F., Perretti, M., & Oliani, S. M. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.140 · Cited by 37
Dejager, L., Pinheiro, I., Puimège, L., Fan, Y.-D., Gremeaux, L., Vankelecom, H. E. J., & Libert, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154484 · Cited by 36
Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia
Remmelts, H. H. F., Meijvis, S. C. A., Heijligenberg, R., Rijkers, G. T., Oosterheert, J. J., Bos, W. J. W., Endeman, H., Grutters, J. C., Hoepelman, A. I. M., & Biesma, D. H. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.03.008 · Cited by 34
A liposomal steroid nano-drug for treating systemic lupus erythematosus
Moallem, E., Koren, E., Ulmansky, R., Pizov, G., Barlev, M., Barenholz, Y., & Naparstek, Y. (2016) · Lupus · doi:10.1177/0961203316636468 · Cited by 36
Glucocorticoid receptor GRβ regulates glucocorticoid-induced ocular hypertension in mice
Patel, G. C., Liu, Y., Millar, J. C., & Clark, A. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-19262-9 · Cited by 35
Gao, W., Wang, L., Wang, K., Sun, L., Rao, Y., Ma, A., Zhang, M., Li, Q., & Yang, H. Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10536 · Cited by 35
Preparing the First Responders: Building the Inflammatory Transcriptome from the Ground Up
Rogatsky, I., & Adelman, K. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.038 · Cited by 39
“1951); however, the lack of selectivity and side effects of traditional GCs demand a better understanding of GR biology (Rhen and Cidlowski, 2005).”
Pharmacological therapies for acute respiratory distress syndrome
Spieth, P. M., & Zhang, H. (2013) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000056 · Cited by 40
Yu, H., Kuo, H., Chen, C., Sheen, J., Tiao, M., Chen, Y., Chang, K., Tain, Y., & Huang, L. (2014) · Immunology · doi:10.1111/imm.12346 · Cited by 33
Simion, V., Constantinescu, C. A., Stan, D. L., Deleanu, M., Tucureanu, M. M., Butoi, E. D., Mânduțeanu, I., Simionescu, M., & Călin, M. (2016) · Mediators of Inflammation · doi:10.1155/2016/1625149 · Cited by 36
“Alternatively, the GR can complex other transcription factors in the cytosol, like NFκB or AP-1, preventing their translocation in the nucleus and inhibiting the expression of proinflammatory molecules [17].”
BackgroundResultNew Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets
Xu, B., Harb, S. C., & Cremer, P. C. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0866-6 · Cited by 33
Nuclear receptors in neural stem/progenitor cell homeostasis
Gkikas, D., Tsampoula, M., & Politis, P. K. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2571-4 · Cited by 33
Human lung tissue provides highly relevant data about efficacy of new anti-asthmatic drugs
Danov, O., Delgado, S. M. J., Obernolte, H., Seehase, S., Dehmel, S., Braubach, P., Fieguth, H., Matschiner, G., Fitzgerald, M. F., Jonigk, D. D., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207767 · Cited by 34
“Yet, side-effects and reduced effectiveness in steroid-resistent patients [14, 15] highlight the unmet medical need for the development of novel therapies.”
BackgroundMinimal manifestation status and prednisone withdrawal in the MGTX trial
Lee, I. J., Kuo, H., Aban, I., Cutter, G., McPherson, T., Kaminski, H. J., Sussman, J. D., Ströbel, P., Oger, J. J.-F., Cea, G., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010031 · Cited by 36
“Hospitalization other than for thymectomy and/or initiation of prednisone therapy 43 (35) 16 (25) 27 (47) 0.”
BackgroundOutcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis
Delfs, N., Struja, T., Gafner, S., Muri, T., Baechli, C., Schüetz, P., Müeller, B., & Blum, C. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124079 · Cited by 35
“Glucocorticoids (GCs) are frequently used as anti-inflammatory agents [1], and their use has recently massively increased in patients with COVID-19 [2].”
BackgroundNorthcott, M., Gearing, L. J., Nim, H. T., Nataraja, C., Hertzog, P. J., Jones, S. A., & Morand, E. F. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00006-0 · Cited by 36
Balani, S. S., Jensen, C. J., Kouri, A. M., & Kizilbash, S. J. (2021) · Pediatric Transplantation · doi:10.1111/petr.14077 · Cited by 33
Pasqua, L. G. D., Cagna, M., Berardo, C., Vairetti, M., & Ferrigno, A. (2022) · Biomedicines · doi:10.3390/biomedicines10010194 · Cited by 37
“Synthetic glucocorticoids (GCs), such as dexamethasone, betamethasone, prednisolone and triamcinolone, control various physiological functions including development, homeostasis, metabolism, cognition and inflammation [172] and are generally employed for their anti-inflammatory properties at high doses and prolonged p…”
BackgroundPharmacological Treatment for Neuroinflammation in Stress-Related Disorder
Lee, D.-H., Lee, J., Hong, D.-Y., Lee, E.-C., Park, S.-W., Lee, Y. K., & Oh, J. S. (2022) · Biomedicines · doi:10.3390/biomedicines10102518 · Cited by 34
“The activated glucocorticoid complex regulates the expression of anti-inflammatory proteins and inhibits the expression of pro-inflammatory proteins [36].”
BackgroundAnti-inflammatory and Immunosuppressive Agents in PAH
Meloche, J., Renard, S., Provencher, S., & Bonnet, S. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-38664-0_18 · Cited by 38
“Inhibition of this transcription factor, therefore, blunts the immune system capacity to mount a response (Rhen and Cidlowski 2005).”
BackgroundMolecular mechanisms of pain in crystal-induced arthritis
Ramonda, R., Oliviero, F., Galozzi, P., Frallonardo, P., Lorenzin, M., Ortolan, A., Scanu, A., & Punzi, L. (2015) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2015.04.025 · Cited by 33
Ryan, J. C., Morey, J. S., Bottein, M. D., Ramsdell, J. S., & Dolah, F. M. V. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-107 · Cited by 35
“Significantly, glucocorticoids up-regulate anti-inflammatory gene expression while also suppressing inflammatory gene expression [34].”
BackgroundGuo, C., Wang, W., Liu, C., Myatt, L., & Sun, K. (2014) · Endocrinology · doi:10.1210/en.2013-1848 · Cited by 33
Helms, C. M., Messaoudi, I., Jeng, S., Freeman, W. M., Vrana, K. E., & Grant, K. A. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01685.x · Cited by 37
“, 2011), perhaps preventing glucocorticoid responses to infection that could moderate inflammation (Rhen and Cidlowski, 2005).”
Carraro, J. C. C., Mansego, M. L., Milagro, F. I., Chaves, L. O., Vidigal, F. D. C., Bressan, J., & Martínez, J. A. (2016) · Biomarkers · doi:10.3109/1354750x.2016.1171904 · Cited by 35
“…transcription factors to DNA sequence due to increased methylation can lead, in the first case, to decreased modulation of leptin gene and lower regulation of energy homeostasis (Wang et al., 1995), and, in another case, to lower expression of anti-inflammatory proteins (Rhen & Cidlowski, 2005).”
BackgroundKuo, T., Chen, T.-C., Lee, R. A., Nguyen, N. H. T., Broughton, A. E., Zhang, D., & Wang, J.-C. (2017) · Diabetes · doi:10.2337/db16-0831 · Cited by 35
“Although exogenous GCs are frequently prescribed as effective anti-inflammatory agents, their actions in metabolic tissues pose a therapeutic conundrum (4).”
Importance of glucocorticoid receptors in upper and lower airways
Pujols, L., Mullol, J., & Picado, C. (2009) · Frontiers in bioscience · doi:10.2741/3646 · Cited by 34
“Numerous outstanding reviews have been recently published along these lines (4-12).”
BackgroundReplacement therapy for Addison's disease: recent developments
Løvås, K., & Husebye, E. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.497 · Cited by 32
“The GR is a nuclear receptor that is ubiquitously expressed in all human cells, however in multiple splice and translation variants that most likely differ between tissues and individuals [48] .”
BackgroundLee, R., Greenwood, R., Taylor, H., Amer, R., Biester, S., Heissigerová, J., Forrester, J. V., & Dick, A. D. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.030 · Cited by 32
Epigenetics in the treatment of systemic lupus erythematosus: Potential clinical application
Guo, Y., Sawalha, A. H., & Lu, Q. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.09.002 · Cited by 32
Immunosuppressive Effects in Infants Treated With Corticosteroids for Infantile Hemangiomas
Kelly, M. E., Juern, A. M., Grossman, W. J., Schauer, D. W., & Drolet, B. A. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.90 · Cited by 35
Itakura, T., Peters, D. M. P., & Fini, M. E. (2015) · PubMed Central · Cited by 40
Preventive effects of supplemental dietary zinc on heat-induced damage in the epididymis of boars
Li, Z., Li, Y., Zhou, X. E., Cao, Y., & Li, C. (2017) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2017.01.002 · Cited by 35
Sawamura, M., Komatsuda, A., Togashi, M., Wakui, H., & Takahashi, N. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.7797 · Cited by 32
“Glucocorticoids (GCs) are widely used to treat various inflammatory disorders, including rheumatic and renal diseases (1), and improve the outcomes of these diseases.”
BackgroundIs there a safe and effective way to wean patients off long‐term glucocorticoids?
Baker, E. H. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14679 · Cited by 38
“Prolonged and/or high dose glucocorticoid therapy promotes gluconeogenesis, protein catabolism and lipolysis, reduces proliferation of actively dividing cells, promotes apoptosis, inhibits the synthesis of extracellular matrix proteins, has vasopressor effects and suppresses the hypothalamic pituitary axis.(3) Adverse…”
Metadata
- Authors
- Rhen, T., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-20
- Volume
- 353
- Issue
- 16
- Pages
- 1711-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150691073
- Cited by
- 3,149
- References
- 93
- Citations by year
- 2026: 123 · 2025: 122 · 2024: 152 · 2023: 155 · 2022: 188 · 2021: 220 · 2020: 214 · 2019: 164 · 2018: 153 · 2017: 173 · 2016: 183 · 2015: 176 · 2014: 163 · 2013: 167 · 2012: 136
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- glucocorticoids, anti-inflammatory mechanism, inflammation, glucocorticoid adverse effects, drug mechanisms of action
- MeSH terms
- Anti-Inflammatory Agents, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.